Migraine and tension-type headache

Case scenario Chau, a 23-year-old female, requests 'something strong for migraine'. She tells you she is developing a headache, has sensitivity to light and awful...

Future health series: pharmacy can adjust the sails

It’s no longer plain sailing in Australian community pharmacy. Bruce Annabel helps navigate in this, the fourth instalment of our Future Health series. Most...

PSA’s up-to-date COVID-19 advice for pharmacists

As the number of COVID-19 cases continues to rise in Australia, PSA is working to ensure pharmacists’ needs are considered in pandemic planning.

Update on breast cancer risk with HRT

Hormone replacement therapy may pose a risk to the development of breast cancer, according to new research. The incidence of breast cancer is higher in...

Will a repurposed drug help treat COVID-19?

There are 344 registered interventional clinical trials under way for the treatment and prevention of COVID-19. The WHO is looking at four of them.

NIP access (almost) guaranteed

The state's major parties have committed to allowing pharmacist immunisers to access the National Immunisation Program (NIP) for the first time.